Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
4/8/2024
Boehringer Ingelheim and Sino Biopharm Enter Strategic Deal to Develop...
4/5/2024
UB and 7th Affiliated Hospital of SYU Launch A Joint Clinical Research...
4/4/2024
Rohto and Mitsui to Buy TCM Company for $590M
4/3/2024
Genmab A/S to Acquire ADC Developer ProfoundBio for $1.8B Cash
4/2/2024
Takeda's Drive: Elevating Chinese Clinical Trials and Global Health
4/2/2024
Aurisco Launches State-of-the-Art Manufacturing Facility for GLP-1 Pep...
4/1/2024
CMS and Incyte Enter License Deal for Povorcitinib in China and SE Asi...
4/1/2024
Congress Targets Biotech Suppliers for Pentagon Watchlist Amid China S...
3/30/2024
Financial-related Company News Digest (March 2024)
3/27/2024
Mitsui & Rohto-led Consortium Near Deal to Acquire Eu Yan Sang
3/27/2024
Oncology Partnerships in China Account for 41% of All Deals Over Past ...
3/27/2024
AstraZeneca Plans to Divide Drug Production between US and China Amid ...
3/26/2024
AZ and Pfizer CEOs Pledge Support for China's Biopharma Industry Growt...
3/26/2024
Stemirna Therapeutics Faces Setback as Cancer Vaccine Trial Halts
3/26/2024
AriBio Licenses Alzheimer's Pill in China for Up to $770M
3/26/2024
Big Pharma CEOs Pledge Commitment at China Development Forum 2024
3/26/2024
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction
3/22/2024
Joincare Licenes Bayer's Small Molecule Drug for COPD
3/21/2024
U.S. Biz Leaders Including Pharma CEOs Set to Meet Chinese President X...
3/20/2024
WuXi XDC Builds Singapore Manufacturing Facility for Global Bioconjuga...
3/20/2024
WuXi Biologics Breaks Ground on State-of-the-Art $1.4 Billion CRDMO Fa...
3/19/2024
Challenges in Accessing Paxlovid Amidst Rising COVID-19 Cases in China
3/19/2024
Novo Nordisk Invests CNY 4B Into Flagship Tianjin Plant Expansion Ahea...
3/19/2024
Zuellig Pharma and Karo Healthcare strengthen partnership across key m...
3/18/2024
Bio-Thera Solutions Partners with SteinCares to Market Two Biosimilars...
3/15/2024
Unveiling Quality of Clinical Trial in China: from Concern to Confirma...
3/15/2024
Biotheus and Hansoh Pharma Expand ADC Collaboration
3/15/2024
Chinese Pharma Stocks Surge amid Speculation of Government Support for...
3/13/2024
Biotech Lobby Group BIO to Sever Ties with WuXi Amid National Security...
3/12/2024
BIO Faces Criticism for Involvement in Legislation Concerning China's ...
Page:
1
/
13
Total number of articles:
374
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit